Literature DB >> 15937639

Postmortem mu-opioid receptor binding in suicide victims and controls.

G Zalsman1, A Molcho, Y Huang, A Dwork, S Li, J J Mann.   

Abstract

BACKGROUND: Endogenous opiates may reinforce self-injurious behavior in animal and human subjects. Higher postmortem mu-opioid receptor binding is reported in some brain regions in young compared with older suicide victims. The present study compared opioid receptor binding kinetics in postmortem brains of young suicide victims and matched controls in two brain areas.
METHODS: The density (Bmax) and affinity (K(D)) of the mu-opioid receptors were assayed postmortem using [3H] DAGO in prefrontal cortex (PFC) and pre-post central gyri (PPCG) in 9 suicide victims and 10 controls, matched for age and gender ratio.
RESULTS: Binding indices did not differ between suicide victims and controls in either brain area and did not correlate with age. PFC Bmax was higher than PPCG Bmax (F=8.030; df=1,16; p=.012) for the combined sample. There was no brain region difference in K(D) between PFC and PPCG, but the interaction between K(D) and group was significant (F = 5.890; df = 1,16; p = .027). The K(D) in the suicide victims was lower than controls in the PFC and higher than controls in the PPCG.
CONCLUSION: Our study demonstrated more mu-opioid receptors in PFC compared with PPCG binding regardless of suicide status. The region-dependent differences in binding affinity in suicide victims may reflect regionally different opiate transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15937639     DOI: 10.1007/s00702-004-0239-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides.

Authors:  A Hishimoto; H Cui; K Mouri; H Nushida; Y Ueno; K Maeda; O Shirakawa
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

Review 2.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 3.  Neurobiology of suicide: do biomarkers exist?

Authors:  Alessandra Costanza; Isabella D'Orta; Nader Perroud; Sandra Burkhardt; Alain Malafosse; Patrice Mangin; Romano La Harpe
Journal:  Int J Legal Med       Date:  2013-02-22       Impact factor: 2.686

4.  Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals.

Authors:  Albert J Arias; Grace Chan; Joel Gelernter; Lindsay Farrer; Henry R Kranzler
Journal:  Am J Addict       Date:  2011-12-15

Review 5.  Opioid system and human emotions.

Authors:  Lauri Nummenmaa; Lauri Tuominen
Journal:  Br J Pharmacol       Date:  2017-05-24       Impact factor: 8.739

6.  Multiple suicide attempts associated with addiction to tramadol.

Authors:  Bénédicte Nobile; Marine Bonnin; Emilie Olié; Philippe Courtet
Journal:  Ann Gen Psychiatry       Date:  2022-07-01       Impact factor: 3.301

7.  The Role of Opiates in Social Pain and Suicidal Behavior.

Authors:  Benedicte Nobile; Pierre-Eric Lutz; Emilie Olie; Philippe Courtet
Journal:  Curr Top Behav Neurosci       Date:  2020

Review 8.  Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

9.  Increased functional coupling of the mu opioid receptor in the anterior insula of depressed individuals.

Authors:  Pierre-Eric Lutz; Daniel Almeida; Dominique Filliol; Fabrice Jollant; Brigitte L Kieffer; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2021-02-02       Impact factor: 7.853

10.  Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.

Authors:  Elizabeth Scarr; Tammie Terese Money; Geoffrey Pavey; Jaclyn Neo; Brian Dean
Journal:  BMC Psychiatry       Date:  2012-08-28       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.